Retracted: Distinct Molecular Subtypes of Diffuse Large B Cell Lymphoma Patients Treated with Rituximab-CHOP Are Associated with Different Clinical Outcomes and Molecular Mechanisms

Biomed Res Int. 2024 Mar 20;2024:9846925. doi: 10.1155/2024/9846925. eCollection 2024.ABSTRACT[This retracts the article DOI: 10.1155/2021/5514726.].PMID:38550212 | PMC:PMC10977124 | DOI:10.1155/2024/9846925

Source: Biomed Res - March 29, 2024 Category: Research Authors: BioMed Research International Source Type: research